Vimarsana
Biggest News Aggregation in the World

Page 2 - Statistical Computing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Statistical Computing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Statistical Computing Today - Breaking & Trending Today

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients - Vimarsana News

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.

Source: ajmc.com
Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates | Surgery | JAMA - Vimarsana News

Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates | Surgery | JAMA

This study develops and validates a multivariable prediction model to rank order adult heart transplant candidates by medical urgency.

Mass Azithromycin Distribution to Prevent Child Mortality - Vimarsana News

Mass Azithromycin Distribution to Prevent Child Mortality

This cluster randomized placebo-controlled trial examines the efficacy of single-dose azithromycin for prevention of all-cause childhood mortality in rural Burk

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis | Cerebrovascular Disease | JAMA - Vimarsana News

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis | Cerebrovascular Disease | JAMA

This individual participant data meta-analysis assesses treatment time from stroke symptom onset and disability level after treatment with intravenous thromboly

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years | Public Health | JAMA - Vimarsana News

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years | Public Health | JAMA

This study uses data from 3 prospective cohort studies conducted in the US to assess vaccine effectiveness of bivalent COVID-19 vaccines against SARS-CoV-2 infe